Literature DB >> 23093651

Airway inflammation in patients with chronic non-asthmatic cough.

Marcin Grabowski1, Sven Seys, Ann Decraene, Ahmad Kasran, Ellen Dilissen, Wojciech Barg, Wojciech Medrala, Lieven J Dupont, Bernard Panaszek, Dominique M A Bullens.   

Abstract

INTRODUCTION: Chronic non-asthmatic cough (CC) is a clinical challenge and underlying pathophysiological mechanisms remain still not completely understood. One of the most common comorbidities in CC is gastro-oesophageal reflux disease (GORD). Airway epithelium damage can contribute to airway inflammation in CC. AIMS: We studied airway inflammation in patients with CC compared to healthy controls. Patients with GORD were treated with proton pump inhibitors (PPI) and cough response to PPI was evaluated. PATIENTS AND METHODS: Sputum was induced in 41 adults with CC and 20 healthy non-smokers who were age and sex matched. We compared sputum differential cell count by cytospin and cytokine and chemokine production at the mRNA and/or protein levels by real-time (RT)-PCR and cytokine bead array (CBA), between patients with CC and healthy subjects. Furthermore we studied airway inflammation in patients with different comorbidities.
RESULTS: No differences in sputum differential cell counts were observed between patients with CC and healthy subjects. Sputum monocyte chemoattractant protein-1 (MCP-1) protein levels were significantly higher in patients when compared to controls. Thymic stromal lymphopoietin (TSLP) mRNA was significantly more often expressed in sputum of patients with CC than from healthy controls. Sputum transforming growth factor (TGF)-β levels did not differ between patients and controls, but were significantly lower in the PPI responders compared to the non-responders; p=0.047. There is no evidence for impaired T helper cell (Th)1/Th2/Th17 balance in CC. Patients with reflux oesophagitis (RO) have significantly more sputum eosinophils than patients without RO.
CONCLUSIONS: CC is a condition presenting with different disease phenotypes. High sputum MCP-1 levels are present in a large group of patients with CC and a majority of these patients with CC have increased sputum TSLP levels, most likely produced by damaged airway epithelial cells.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23093651     DOI: 10.1136/thoraxjnl-2012-201895

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  3 in total

Review 1.  Chronic cough: a gastroenterology perspective.

Authors:  Andrew J Gawron; Peter J Kahrilas; John E Pandolfino
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2013-12       Impact factor: 2.064

Review 2.  Cough hypersensitivity as a neuro-immune interaction.

Authors:  Woo-Jung Song; Yoon-Seok Chang
Journal:  Clin Transl Allergy       Date:  2015-07-15       Impact factor: 5.871

3.  Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients.

Authors:  Sven F Seys; Hans Scheers; Paul Van den Brande; Gudrun Marijsse; Ellen Dilissen; Annelies Van Den Bergh; Pieter C Goeminne; Peter W Hellings; Jan L Ceuppens; Lieven J Dupont; Dominique M A Bullens
Journal:  Respir Res       Date:  2017-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.